Insider Trading & Ownership - SCHEIBLER LUKAS

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SCHEIBLER LUKAS
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-12-01
Sale		 2023-12-05
7:40 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 10,000 $60 $600,000 107,690
(Direct)		 View
2023-09-06
Sale		 2023-09-07
4:08 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 1,756 $43.01 $75,526 68,299
(Direct)		 View
2022-05-27
Sale		 2022-05-31
4:30 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $43 $430,000 42,233
(Direct)		 View
2022-04-05
Sale		 2022-04-06
4:10 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 609 $60.09 $36,593 101,624
(Direct)		 View
2022-04-04
Sale		 2022-04-05
4:08 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 3,504 $56.96 $199,589 102,233
(Direct)		 View
2022-04-01
Sale		 2022-04-04
5:03 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 11,496 $55.05 $632,855 105,737
(Direct)		 View
2022-02-11
Sale		 2022-02-14
6:20 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 1,666 $46.8 $77,969 51,513
(Direct)		 View
2022-02-10
Sale		 2022-02-14
4:15 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $50 $500,000 118,179
(Direct)		 View
2022-02-08
Sale		 2022-02-10
08:32 am		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $45 $450,000 128,857
(Direct)		 View
2022-01-31
Sale		 2022-02-01
5:58 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 1,233 $38.47 $47,434 53,857
(Direct)		 View
2021-06-10
Sale		 2021-06-11
4:07 pm		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 3,417 $60 $205,020 26,651
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2023-12-01
Exercise		 2023-12-05
7:40 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 10,000 $13.85 107,690
(Direct)		 View
2023-12-01
Exercise		 2023-12-05
7:40 pm		 N/A
2029-02-07		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 10,000 $0 107,690
(Direct)		 View
2023-02-21
Tax Withholding		 2023-02-22
06:49 am		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 715 $58.5 83,666
(Direct)		 View
2023-02-21
Option Award		 2023-02-22
06:49 am		 N/A
2032-01-20		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 23,909 $0 83,666
(Direct)		 View
2023-02-10
Tax Withholding		 2023-02-14
4:44 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 678 $51.21 60,472
(Direct)		 View
2023-01-27
Tax Withholding		 2023-01-30
5:03 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 542 $52.77 61,150
(Direct)		 View
2023-01-20
Tax Withholding		 2023-01-24
5:22 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 2,015 $52.05 61,692
(Direct)		 View
2023-01-12
Option Award		 2023-01-17
7:42 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 22,580 $0 99,179
(Direct)		 View
2023-01-12
Option Award		 2023-01-17
7:42 pm		 N/A
2033-01-11		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
Chief Research Officer		 35,472 $52.66 99,179
(Direct)		 View
2022-04-21
Other		 2022-05-31
4:30 pm		 N/A
2031-01-27		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 13,125 $0 42,233
(Direct)		 View
2022-04-05
Exercise		 2022-04-06
4:10 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 609 $13.85 101,624
(Direct)		 View
2022-04-05
Exercise		 2022-04-06
4:10 pm		 N/A
2029-02-07		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 609 $0 101,624
(Direct)		 View
2022-04-04
Exercise		 2022-04-05
4:08 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 3,504 $13.85 102,233
(Direct)		 View
2022-04-04
Exercise		 2022-04-05
4:08 pm		 N/A
2029-02-07		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 3,504 $0 102,233
(Direct)		 View
2022-04-01
Exercise		 2022-04-04
5:03 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 11,496 $13.85 105,737
(Direct)		 View
2022-04-01
Exercise		 2022-04-04
5:03 pm		 N/A
2029-02-07		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 11,496 $0 105,737
(Direct)		 View
2022-02-14
Exercise		 2022-02-15
4:58 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 720 $26.73 186,010
(Direct)		 View
2022-02-14
Exercise		 2022-02-15
4:58 pm		 N/A
2028-04-12		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 720 $0 186,010
(Direct)		 View
2022-02-10
Exercise		 2022-02-14
4:15 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $13.85 118,179
(Direct)		 View
2022-02-10
Exercise		 2022-02-14
4:15 pm		 N/A
2029-02-07		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $0 118,179
(Direct)		 View
2022-02-10
Tax Withholding		 2022-02-14
4:15 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 678 $47.12 118,179
(Direct)		 View
2022-02-08
Exercise		 2022-02-10
08:32 am		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $13.85 128,857
(Direct)		 View
2022-02-08
Exercise		 2022-02-10
08:32 am		 N/A
2029-02-07		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 10,000 $0 128,857
(Direct)		 View
2022-01-28
Tax Withholding		 2022-02-01
5:58 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 642 $38.59 53,857
(Direct)		 View
2022-01-21
Option Award		 2022-01-25
4:58 pm		 N/A
2032-01-20		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 63,002 $0 92,683
(Direct)		 View
2022-01-21
Exercise		 2022-01-24
5:26 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 3,021 $26.73 164,178
(Direct)		 View
2022-01-21
Exercise		 2022-01-24
5:26 pm		 N/A
2028-04-12		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 3,021 $0 164,178
(Direct)		 View
2021-02-10
Tax Withholding		 2021-02-11
4:18 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 680 $47.72 29,290
(Direct)		 View
2021-01-28
Option Award		 2021-02-01
4:39 pm		 N/A
2031-01-27		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 65,625 $0 86,220
(Direct)		 View
2020-12-08
Exercise		 2020-12-09
5:34 pm		 N/A
N/A		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 7,482 $26.73 158,113
(Direct)		 View
2020-12-08
Exercise		 2020-12-09
5:34 pm		 N/A
2028-04-12		 Apellis Pharmaceuticals Inc. APLS SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		 7,482 $0 158,113
(Direct)		 View